BME:YVIV Statistics
Total Valuation
BME:YVIV has a market cap or net worth of EUR 995.58 million. The enterprise value is 1.69 billion.
Market Cap | 995.58M |
Enterprise Value | 1.69B |
Important Dates
The last earnings date was Thursday, May 1, 2025.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BME:YVIV has 732.04 million shares outstanding. The number of shares has increased by 2.52% in one year.
Current Share Class | 732.04M |
Shares Outstanding | 732.04M |
Shares Change (YoY) | +2.52% |
Shares Change (QoQ) | +2.99% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 46.94% |
Float | 388.41M |
Valuation Ratios
The trailing PE ratio is 12.36.
Price/FFO Ratio | n/a |
Price/AFFO Ratio | n/a |
PE Ratio | 12.36 |
Forward PE | n/a |
PS Ratio | 16.65 |
PB Ratio | 0.89 |
P/TBV Ratio | 0.89 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 49.21, with an EV/FCF ratio of -127.01.
EV / Earnings | 21.31 |
EV / Sales | 28.31 |
EV / EBITDA | 49.21 |
EV / EBIT | 49.54 |
EV / FCF | -127.01 |
Financial Position
The company has a current ratio of 0.03, with a Debt / Equity ratio of 0.63.
Current Ratio | 0.03 |
Quick Ratio | 0.03 |
Debt / Equity | 0.63 |
Debt / EBITDA | 20.33 |
Debt / FCF | -52.49 |
Interest Coverage | 1.63 |
Financial Efficiency
Return on equity (ROE) is 7.48% and return on invested capital (ROIC) is 1.26%.
Return on Equity (ROE) | 7.48% |
Return on Assets (ROA) | 1.22% |
Return on Invested Capital (ROIC) | 1.26% |
Return on Capital Employed (ROCE) | 1.96% |
Revenue Per Employee | 664,544 |
Profits Per Employee | 882,689 |
Employee Count | 90 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.74% in the last 52 weeks. The beta is -0.00, so BME:YVIV's price volatility has been lower than the market average.
Beta (5Y) | -0.00 |
52-Week Price Change | +0.74% |
50-Day Moving Average | 1.35 |
200-Day Moving Average | 1.35 |
Relative Strength Index (RSI) | 99.38 |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:YVIV had revenue of EUR 59.81 million and earned 79.44 million in profits. Earnings per share was 0.11.
Revenue | 59.81M |
Gross Profit | 54.01M |
Operating Income | 34.18M |
Pretax Income | 98.13M |
Net Income | 79.44M |
EBITDA | 34.41M |
EBIT | 34.18M |
Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 2.17 million in cash and 699.65 million in debt, giving a net cash position of -697.48 million or -0.95 per share.
Cash & Cash Equivalents | 2.17M |
Total Debt | 699.65M |
Net Cash | -697.48M |
Net Cash Per Share | -0.95 |
Equity (Book Value) | 1.12B |
Book Value Per Share | 1.53 |
Working Capital | -128.64M |
Cash Flow
In the last 12 months, operating cash flow was -13.16 million and capital expenditures -175,000, giving a free cash flow of -13.33 million.
Operating Cash Flow | -13.16M |
Capital Expenditures | -175,000 |
Free Cash Flow | -13.33M |
FCF Per Share | -0.02 |
Margins
Gross margin is 90.31%, with operating and profit margins of 57.15% and 132.83%.
Gross Margin | 90.31% |
Operating Margin | 57.15% |
Pretax Margin | 164.08% |
Profit Margin | 132.83% |
EBITDA Margin | 57.53% |
EBIT Margin | 57.15% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.52%.
Dividend Per Share | 0.01 |
Dividend Yield | 0.52% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | 6.17% |
Buyback Yield | -2.52% |
Shareholder Yield | -2.00% |
Earnings Yield | 7.98% |
FCF Yield | -1.34% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |